Azacitidin Spirig HC 100 mg, Pulver zur Herstellung einer Injektionssuspension
7680682730018
CH-68273
Pulver zur Herstellung einer Injektionssuspension
Associated product:
AZACITIDINE Spirig HC subst sèche 100 mg flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver zur Herstellung einer Injektionssuspension
- Galenic group
- Lösbar zur Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 259.95
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/05/2021
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 68273
- Drug name
- Azacitidin Spirig HC, Pulver zur Herstellung einer Injektionssuspension
- Galenic form
- PULVS
- ATC Code
- L01BC07
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 15/02/2021
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.16.1.
- Domain
- Human medicine
Package details
- Description (FR)
- AZACITIDINE Spirig HC subst sèche 100 mg flac
- Description (DE)
- AZACITIDIN Spirig HC Trockensub 100 mg Durchstf
- Market launch
- 15/02/2021
- Narcotic (BTM)
- No
Original drug
Vidaza, Lyophilisat zur Herstellung einer Injektionssuspension
GTIN: 7680573800011
CHF 350.75